Clostridium difficile toxin A and toxin B inhibit YAP in the colonic epithelial cells. Issue 2 (30th November 2020)

• Record Type: Journal Article
• Authors: Song, Jinglue; Shen, Xia; Huang, Zhenyu; Liu, Yun; Cui, Long; Cui, Xuewei; Liu, Chen‐Ying
• Is Part Of: Journal of biochemical and molecular toxicology. Volume 35:Issue 2(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-11-30
• Subjects: Clostridium difficile -- TAZ -- toxin A -- toxin B -- YAP; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Toxicology -- Periodicals; 574
• DOI: 10.1002/jbt.22652
• Languages: English
• ISSNs: 1095-6670

Abstract

Abstract: Toxin A (TcdA) and toxin B (TcdB), the two exotoxins of Clostridium difficile, are main causal agents for the colonic epithelium damage in Clostridium difficile infection (CDI). The Hippo pathway is crucial for the control of tissue homeostasis and regeneration of intestines. However, the dysregulation of Hippo pathway in CDI is unclear. Here we show that YAP and TAZ, the transcriptional coactivators downstream of the Hippo pathway, are sequestered in the cytoplasm, degraded, and inactivated by treatment with TcdA and TcdB in colonic epithelial cells. The overexpression of YAP restores the messenger RNA expressions of YAP target genes, attenuates the disruption of cytoskeleton and cell rounding, and rescues the cell proliferation of colonic epithelial cells under exposure of the two toxins. Our results demonstrate that inhibition of YAP and TAZ is involved in the pathogenesis of CDI, implicating that increasing YAP activity could be a potential therapeutic strategy for the CDI treatment.